Ledger.Open graph →
SEC Form D · filed August 24, 2012

INTERCEPT PHARMACEUTICALS INC

Offering
$30.0M
Sold
$15.0M
Exemption
Industry
Biotechnology
Location
NEW YORK, NY
Type

People & firms on this filing (18)

Barbara Duncan · New York, NYExecPaolo Fundaro · New York, NYDirectorLuciano Adorini · New York, NYExecMark E. Pruzanski · New York, NYExec · DirectorJonathan T. Silverstein · New York, NYDirectorNicole Williams · New York, NYDirectorDavid Shapiro · New York, NYExecLorenzo Tallarigo · New York, NYDirectorKlaus Veitinger · New York, NYDirectorHoward Schwartz · Norwalk, CTExec · DirectorFranklin J. Trotter · Hampton, NHExecAndrew Garman · Hampton, NHDirectorJohn Wallace · Hampton, NHDirectorJames W. Bennett · Hampton, NHExecWillie E. Woods · New York, NYExecLloyd M. Metz · New York, NYDirectorLorenzo Tallarigo · New York, NYDirectorKlaus Veitinger · Newark, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗